Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series

BACKGROUND: Because evidence on the safety of COVID-19 vaccines in older adults is scarce, we aimed to evaluate the incidence and risk of adverse events after CoronaVac (Sinovac Biotech) vaccination in adults aged 60 years or older. METHODS: In this modified self-controlled case series, we enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Eric Yuk Fai, Wang, Yuan, Chui, Celine Sze Ling, Mok, Anna Hoi Ying, Xu, Wanchun, Yan, Vincent Ka Chun, Lai, Francisco Tsz Tsun, Li, Xue, Wong, Carlos King Ho, Chan, Esther Wai Yin, Lau, Kui Kai, Cowling, Benjamin John, Hung, Ivan Fan Ngai, Wong, Ian Chi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252509/
https://www.ncbi.nlm.nih.gov/pubmed/35813276
http://dx.doi.org/10.1016/S2666-7568(22)00125-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252509/
https://www.ncbi.nlm.nih.gov/pubmed/35813276
http://dx.doi.org/10.1016/S2666-7568(22)00125-8

Ejemplares similares